Moreover, only a small fraction of patients with lung cancer with EGFR mutations (<5%) experience a complete response [4,5,6,7,8], although the EGFR mutation is a truncal mutation and is homogeneously distributed (i.e., virtually all tumor cells harbor the same EGFR mutation) [15,16,17]. The gene discussed is EGFR; the disease is neoplasm.